Company intelligence / Profile preview

Enovis

Wilmington, Delaware, United Statesenovis.com ↗

Ownership: Public · ENOV
Employees: ~8000
Development stage: Commercial

Overview

Enovis develops and markets a broad portfolio of orthopedic medical devices and technologies. Its products are used in surgical procedures such as total hip and knee arthroplasty as well as non-surgical bracing/supports and post-operative rehabilitation. The company’s ARVIS® system provides augmented reality guidance for surgeons during joint replacement procedures. Enovis has completed several strategic acquisitions to expand its product offerings globally.

Therapeutic areas: NeurologyRheumatology
Modalities: Device
Industry: Surgical Medical Devices

Partnerships

No major pharma/biotech partnerships specifically cited in available sources.

Financials

Market cap: $1.2B
Total revenue: $582.8M
Enterprise value: $2.5B

Beyond the preview

Go deeper on Enovis.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Enovis.

Explore the full profile